Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine

Angela Rose, Marta Valenciano(World Health Organization), Valeria Alfonsi(Istituto Superiore di Sanità), Ritva Syrjänen(Finnish Institute for Health and Welfare), Jesús Castilla(Instituto de Salud Pública de Navarra), Verónica Gomez(National Institute of Health Dr. Ricardo Jorge), Zvjezdana Lovrić Makarić, Esther Kissling, Bruno Lina(Université Claude Bernard Lyon 1), Adam Meijer(National Centre for Infectious Diseases), Antonino Bella(Istituto Superiore di Sanità), Niina Ikonen(Finnish Institute for Health and Welfare), Sanja Filipović(Hrvatski zavod za javno zdravstvo), Itziar Casado(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Alin Gherasim(Instituto de Salud Carlos III), Monika Kuliešė(Lithuanian University of Health Sciences), Sierk Marbus(Leiden University Medical Center), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Odile Launay(Délégation Paris 5), Alain Moren(Health Service Executive), Florence Galtier(Inserm), Auksė Mickienė(Lithuanian University of Health Sciences), Mihaela Lazăr
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
January 1, 2020
Cited by 0


Related Papers